nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—germ cell cancer—melanoma	0.29	1	CtDrD
Ifosfamide—Alkylating Activity—Temozolomide—melanoma	0.225	0.368	CiPCiCtD
Ifosfamide—Alkylating Activity—Carmustine—melanoma	0.205	0.337	CiPCiCtD
Ifosfamide—Alkylating Activity—Dacarbazine—melanoma	0.18	0.295	CiPCiCtD
Ifosfamide—CYP3A4—Temozolomide—melanoma	0.011	0.285	CbGbCtD
Ifosfamide—CYP3A7—Docetaxel—melanoma	0.00705	0.183	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.00705	0.183	CbGbCtD
Ifosfamide—CYP3A4—Vemurafenib—melanoma	0.00601	0.156	CbGbCtD
Ifosfamide—CYP3A5—Docetaxel—melanoma	0.00529	0.138	CbGbCtD
Ifosfamide—CYP3A4—Docetaxel—melanoma	0.00206	0.0537	CbGbCtD
Ifosfamide—Cyclophosphamide—ABCB1—melanoma	8.67e-05	1	CrCbGaD
Ifosfamide—Urinary tract disorder—Temozolomide—melanoma	6.49e-05	0.00114	CcSEcCtD
Ifosfamide—Cardiac failure—Docetaxel—melanoma	6.48e-05	0.00114	CcSEcCtD
Ifosfamide—Pruritus—Vemurafenib—melanoma	6.47e-05	0.00114	CcSEcCtD
Ifosfamide—Connective tissue disorder—Temozolomide—melanoma	6.46e-05	0.00114	CcSEcCtD
Ifosfamide—Urethral disorder—Temozolomide—melanoma	6.45e-05	0.00114	CcSEcCtD
Ifosfamide—Alopecia—Dactinomycin—melanoma	6.43e-05	0.00113	CcSEcCtD
Ifosfamide—Eye disorder—Carmustine—melanoma	6.36e-05	0.00112	CcSEcCtD
Ifosfamide—Visual impairment—Temozolomide—melanoma	6.34e-05	0.00112	CcSEcCtD
Ifosfamide—Erythema—Dactinomycin—melanoma	6.33e-05	0.00112	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Docetaxel—melanoma	6.32e-05	0.00111	CcSEcCtD
Ifosfamide—Pain in extremity—Docetaxel—melanoma	6.32e-05	0.00111	CcSEcCtD
Ifosfamide—Flushing—Carmustine—melanoma	6.32e-05	0.00111	CcSEcCtD
Ifosfamide—Ill-defined disorder—Bleomycin—melanoma	6.3e-05	0.00111	CcSEcCtD
Ifosfamide—Anaemia—Bleomycin—melanoma	6.27e-05	0.00111	CcSEcCtD
Ifosfamide—Diarrhoea—Vemurafenib—melanoma	6.26e-05	0.0011	CcSEcCtD
Ifosfamide—Erythema multiforme—Temozolomide—melanoma	6.22e-05	0.0011	CcSEcCtD
Ifosfamide—Eye disorder—Temozolomide—melanoma	6.15e-05	0.00108	CcSEcCtD
Ifosfamide—Tinnitus—Temozolomide—melanoma	6.13e-05	0.00108	CcSEcCtD
Ifosfamide—Malaise—Bleomycin—melanoma	6.12e-05	0.00108	CcSEcCtD
Ifosfamide—Cardiac disorder—Temozolomide—melanoma	6.1e-05	0.00108	CcSEcCtD
Ifosfamide—Flushing—Temozolomide—melanoma	6.1e-05	0.00108	CcSEcCtD
Ifosfamide—Arrhythmia—Carmustine—melanoma	6.08e-05	0.00107	CcSEcCtD
Ifosfamide—Leukopenia—Bleomycin—melanoma	6.07e-05	0.00107	CcSEcCtD
Ifosfamide—Dizziness—Vemurafenib—melanoma	6.05e-05	0.00107	CcSEcCtD
Ifosfamide—Alopecia—Carmustine—melanoma	6.01e-05	0.00106	CcSEcCtD
Ifosfamide—Angiopathy—Temozolomide—melanoma	5.97e-05	0.00105	CcSEcCtD
Ifosfamide—Mental disorder—Carmustine—melanoma	5.96e-05	0.00105	CcSEcCtD
Ifosfamide—Immune system disorder—Temozolomide—melanoma	5.94e-05	0.00105	CcSEcCtD
Ifosfamide—Mediastinal disorder—Temozolomide—melanoma	5.93e-05	0.00104	CcSEcCtD
Ifosfamide—Erythema—Carmustine—melanoma	5.92e-05	0.00104	CcSEcCtD
Ifosfamide—Malnutrition—Carmustine—melanoma	5.92e-05	0.00104	CcSEcCtD
Ifosfamide—Cough—Bleomycin—melanoma	5.92e-05	0.00104	CcSEcCtD
Ifosfamide—Chills—Temozolomide—melanoma	5.9e-05	0.00104	CcSEcCtD
Ifosfamide—Ill-defined disorder—Dactinomycin—melanoma	5.87e-05	0.00103	CcSEcCtD
Ifosfamide—Anaemia—Dactinomycin—melanoma	5.85e-05	0.00103	CcSEcCtD
Ifosfamide—Vomiting—Vemurafenib—melanoma	5.81e-05	0.00102	CcSEcCtD
Ifosfamide—Alopecia—Temozolomide—melanoma	5.81e-05	0.00102	CcSEcCtD
Ifosfamide—Myalgia—Bleomycin—melanoma	5.78e-05	0.00102	CcSEcCtD
Ifosfamide—Chest pain—Bleomycin—melanoma	5.78e-05	0.00102	CcSEcCtD
Ifosfamide—Rash—Vemurafenib—melanoma	5.76e-05	0.00102	CcSEcCtD
Ifosfamide—Mental disorder—Temozolomide—melanoma	5.76e-05	0.00102	CcSEcCtD
Ifosfamide—Dermatitis—Vemurafenib—melanoma	5.76e-05	0.00101	CcSEcCtD
Ifosfamide—Erythema—Temozolomide—melanoma	5.72e-05	0.00101	CcSEcCtD
Ifosfamide—Malnutrition—Temozolomide—melanoma	5.72e-05	0.00101	CcSEcCtD
Ifosfamide—Breast disorder—Docetaxel—melanoma	5.71e-05	0.00101	CcSEcCtD
Ifosfamide—Discomfort—Bleomycin—melanoma	5.71e-05	0.00101	CcSEcCtD
Ifosfamide—Malaise—Dactinomycin—melanoma	5.71e-05	0.00101	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Docetaxel—melanoma	5.69e-05	0.001	CcSEcCtD
Ifosfamide—Leukopenia—Dactinomycin—melanoma	5.67e-05	0.000998	CcSEcCtD
Ifosfamide—Confusional state—Bleomycin—melanoma	5.58e-05	0.000984	CcSEcCtD
Ifosfamide—Vision blurred—Carmustine—melanoma	5.58e-05	0.000984	CcSEcCtD
Ifosfamide—Anaphylactic shock—Bleomycin—melanoma	5.54e-05	0.000976	CcSEcCtD
Ifosfamide—Oedema—Bleomycin—melanoma	5.54e-05	0.000976	CcSEcCtD
Ifosfamide—Infection—Bleomycin—melanoma	5.5e-05	0.00097	CcSEcCtD
Ifosfamide—Anaemia—Carmustine—melanoma	5.48e-05	0.000965	CcSEcCtD
Ifosfamide—Agitation—Carmustine—melanoma	5.44e-05	0.000959	CcSEcCtD
Ifosfamide—Nausea—Vemurafenib—melanoma	5.43e-05	0.000957	CcSEcCtD
Ifosfamide—Thrombocytopenia—Bleomycin—melanoma	5.42e-05	0.000956	CcSEcCtD
Ifosfamide—Vision blurred—Temozolomide—melanoma	5.4e-05	0.000951	CcSEcCtD
Ifosfamide—Myalgia—Dactinomycin—melanoma	5.39e-05	0.00095	CcSEcCtD
Ifosfamide—Bronchospasm—Docetaxel—melanoma	5.37e-05	0.000947	CcSEcCtD
Ifosfamide—Discomfort—Dactinomycin—melanoma	5.32e-05	0.000938	CcSEcCtD
Ifosfamide—Angina pectoris—Docetaxel—melanoma	5.32e-05	0.000938	CcSEcCtD
Ifosfamide—Ill-defined disorder—Temozolomide—melanoma	5.31e-05	0.000936	CcSEcCtD
Ifosfamide—Leukopenia—Carmustine—melanoma	5.3e-05	0.000934	CcSEcCtD
Ifosfamide—Anaemia—Temozolomide—melanoma	5.29e-05	0.000932	CcSEcCtD
Ifosfamide—Anorexia—Bleomycin—melanoma	5.28e-05	0.00093	CcSEcCtD
Ifosfamide—Agitation—Temozolomide—melanoma	5.26e-05	0.000927	CcSEcCtD
Ifosfamide—Angioedema—Temozolomide—melanoma	5.23e-05	0.000922	CcSEcCtD
Ifosfamide—Pancytopenia—Docetaxel—melanoma	5.19e-05	0.000914	CcSEcCtD
Ifosfamide—Hypotension—Bleomycin—melanoma	5.18e-05	0.000912	CcSEcCtD
Ifosfamide—Oedema—Dactinomycin—melanoma	5.17e-05	0.00091	CcSEcCtD
Ifosfamide—Malaise—Temozolomide—melanoma	5.16e-05	0.00091	CcSEcCtD
Ifosfamide—Vertigo—Temozolomide—melanoma	5.14e-05	0.000906	CcSEcCtD
Ifosfamide—Convulsion—Carmustine—melanoma	5.13e-05	0.000904	CcSEcCtD
Ifosfamide—Infection—Dactinomycin—melanoma	5.13e-05	0.000904	CcSEcCtD
Ifosfamide—Leukopenia—Temozolomide—melanoma	5.12e-05	0.000903	CcSEcCtD
Ifosfamide—Hypertension—Carmustine—melanoma	5.11e-05	0.000901	CcSEcCtD
Ifosfamide—Palpitations—Temozolomide—melanoma	5.06e-05	0.000891	CcSEcCtD
Ifosfamide—Thrombocytopenia—Dactinomycin—melanoma	5.06e-05	0.000891	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Bleomycin—melanoma	5.05e-05	0.000889	CcSEcCtD
Ifosfamide—Chest pain—Carmustine—melanoma	5.04e-05	0.000889	CcSEcCtD
Ifosfamide—Myalgia—Carmustine—melanoma	5.04e-05	0.000889	CcSEcCtD
Ifosfamide—Cough—Temozolomide—melanoma	5e-05	0.00088	CcSEcCtD
Ifosfamide—Paraesthesia—Bleomycin—melanoma	4.97e-05	0.000876	CcSEcCtD
Ifosfamide—Convulsion—Temozolomide—melanoma	4.96e-05	0.000874	CcSEcCtD
Ifosfamide—Hypertension—Temozolomide—melanoma	4.94e-05	0.000871	CcSEcCtD
Ifosfamide—Dyspnoea—Bleomycin—melanoma	4.94e-05	0.00087	CcSEcCtD
Ifosfamide—Anorexia—Dactinomycin—melanoma	4.92e-05	0.000868	CcSEcCtD
Ifosfamide—Pneumonia—Docetaxel—melanoma	4.9e-05	0.000863	CcSEcCtD
Ifosfamide—Confusional state—Carmustine—melanoma	4.87e-05	0.000859	CcSEcCtD
Ifosfamide—Myalgia—Temozolomide—melanoma	4.87e-05	0.000859	CcSEcCtD
Ifosfamide—Arthralgia—Temozolomide—melanoma	4.87e-05	0.000859	CcSEcCtD
Ifosfamide—Infestation—Docetaxel—melanoma	4.87e-05	0.000858	CcSEcCtD
Ifosfamide—Infestation NOS—Docetaxel—melanoma	4.87e-05	0.000858	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	4.84e-05	0.000853	CcSEcCtD
Ifosfamide—Oedema—Carmustine—melanoma	4.83e-05	0.000852	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Docetaxel—melanoma	4.83e-05	0.000851	CcSEcCtD
Ifosfamide—Discomfort—Temozolomide—melanoma	4.82e-05	0.000849	CcSEcCtD
Ifosfamide—Decreased appetite—Bleomycin—melanoma	4.81e-05	0.000848	CcSEcCtD
Ifosfamide—Infection—Carmustine—melanoma	4.8e-05	0.000846	CcSEcCtD
Ifosfamide—Acute coronary syndrome—Docetaxel—melanoma	4.8e-05	0.000846	CcSEcCtD
Ifosfamide—Renal failure—Docetaxel—melanoma	4.79e-05	0.000844	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Docetaxel—melanoma	4.78e-05	0.000841	CcSEcCtD
Ifosfamide—Myocardial infarction—Docetaxel—melanoma	4.78e-05	0.000841	CcSEcCtD
Ifosfamide—Stomatitis—Docetaxel—melanoma	4.75e-05	0.000837	CcSEcCtD
Ifosfamide—Pain—Bleomycin—melanoma	4.74e-05	0.000835	CcSEcCtD
Ifosfamide—Conjunctivitis—Docetaxel—melanoma	4.74e-05	0.000834	CcSEcCtD
Ifosfamide—Thrombocytopenia—Carmustine—melanoma	4.73e-05	0.000834	CcSEcCtD
Ifosfamide—Confusional state—Temozolomide—melanoma	4.71e-05	0.00083	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Dactinomycin—melanoma	4.71e-05	0.000829	CcSEcCtD
Ifosfamide—Oedema—Temozolomide—melanoma	4.67e-05	0.000823	CcSEcCtD
Ifosfamide—Anaphylactic shock—Temozolomide—melanoma	4.67e-05	0.000823	CcSEcCtD
Ifosfamide—Infection—Temozolomide—melanoma	4.64e-05	0.000818	CcSEcCtD
Ifosfamide—Anorexia—Carmustine—melanoma	4.61e-05	0.000812	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Docetaxel—melanoma	4.61e-05	0.000812	CcSEcCtD
Ifosfamide—Nervous system disorder—Temozolomide—melanoma	4.58e-05	0.000807	CcSEcCtD
Ifosfamide—Thrombocytopenia—Temozolomide—melanoma	4.57e-05	0.000806	CcSEcCtD
Ifosfamide—Feeling abnormal—Bleomycin—melanoma	4.56e-05	0.000804	CcSEcCtD
Ifosfamide—Agranulocytosis—Docetaxel—melanoma	4.55e-05	0.000801	CcSEcCtD
Ifosfamide—Skin disorder—Temozolomide—melanoma	4.54e-05	0.0008	CcSEcCtD
Ifosfamide—Hypotension—Carmustine—melanoma	4.52e-05	0.000796	CcSEcCtD
Ifosfamide—Hyperhidrosis—Temozolomide—melanoma	4.52e-05	0.000796	CcSEcCtD
Ifosfamide—Decreased appetite—Dactinomycin—melanoma	4.49e-05	0.000791	CcSEcCtD
Ifosfamide—Fatigue—Dactinomycin—melanoma	4.45e-05	0.000785	CcSEcCtD
Ifosfamide—Anorexia—Temozolomide—melanoma	4.45e-05	0.000785	CcSEcCtD
Ifosfamide—Pain—Dactinomycin—melanoma	4.42e-05	0.000778	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Carmustine—melanoma	4.4e-05	0.000776	CcSEcCtD
Ifosfamide—Urticaria—Bleomycin—melanoma	4.4e-05	0.000775	CcSEcCtD
Ifosfamide—Haemoglobin—Docetaxel—melanoma	4.4e-05	0.000775	CcSEcCtD
Ifosfamide—Body temperature increased—Bleomycin—melanoma	4.38e-05	0.000772	CcSEcCtD
Ifosfamide—Haemorrhage—Docetaxel—melanoma	4.37e-05	0.000771	CcSEcCtD
Ifosfamide—Hepatitis—Docetaxel—melanoma	4.37e-05	0.000771	CcSEcCtD
Ifosfamide—Paraesthesia—Carmustine—melanoma	4.34e-05	0.000765	CcSEcCtD
Ifosfamide—Urinary tract disorder—Docetaxel—melanoma	4.32e-05	0.000761	CcSEcCtD
Ifosfamide—Dyspnoea—Carmustine—melanoma	4.31e-05	0.00076	CcSEcCtD
Ifosfamide—Somnolence—Carmustine—melanoma	4.3e-05	0.000757	CcSEcCtD
Ifosfamide—Connective tissue disorder—Docetaxel—melanoma	4.3e-05	0.000757	CcSEcCtD
Ifosfamide—Urethral disorder—Docetaxel—melanoma	4.29e-05	0.000755	CcSEcCtD
Ifosfamide—Feeling abnormal—Dactinomycin—melanoma	4.26e-05	0.00075	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Temozolomide—melanoma	4.26e-05	0.00075	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Dactinomycin—melanoma	4.22e-05	0.000744	CcSEcCtD
Ifosfamide—Visual impairment—Docetaxel—melanoma	4.21e-05	0.000743	CcSEcCtD
Ifosfamide—Decreased appetite—Carmustine—melanoma	4.2e-05	0.000741	CcSEcCtD
Ifosfamide—Paraesthesia—Temozolomide—melanoma	4.2e-05	0.000739	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Carmustine—melanoma	4.17e-05	0.000735	CcSEcCtD
Ifosfamide—Dyspnoea—Temozolomide—melanoma	4.17e-05	0.000734	CcSEcCtD
Ifosfamide—Somnolence—Temozolomide—melanoma	4.15e-05	0.000732	CcSEcCtD
Ifosfamide—Erythema multiforme—Docetaxel—melanoma	4.14e-05	0.000729	CcSEcCtD
Ifosfamide—Constipation—Carmustine—melanoma	4.13e-05	0.000729	CcSEcCtD
Ifosfamide—Pain—Carmustine—melanoma	4.13e-05	0.000729	CcSEcCtD
Ifosfamide—Eye disorder—Docetaxel—melanoma	4.09e-05	0.00072	CcSEcCtD
Ifosfamide—Body temperature increased—Dactinomycin—melanoma	4.08e-05	0.00072	CcSEcCtD
Ifosfamide—Abdominal pain—Dactinomycin—melanoma	4.08e-05	0.00072	CcSEcCtD
Ifosfamide—Hypersensitivity—Bleomycin—melanoma	4.08e-05	0.000719	CcSEcCtD
Ifosfamide—Decreased appetite—Temozolomide—melanoma	4.06e-05	0.000716	CcSEcCtD
Ifosfamide—Cardiac disorder—Docetaxel—melanoma	4.06e-05	0.000715	CcSEcCtD
Ifosfamide—Flushing—Docetaxel—melanoma	4.06e-05	0.000715	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Temozolomide—melanoma	4.03e-05	0.000711	CcSEcCtD
Ifosfamide—Fatigue—Temozolomide—melanoma	4.03e-05	0.00071	CcSEcCtD
Ifosfamide—Pain—Temozolomide—melanoma	4e-05	0.000704	CcSEcCtD
Ifosfamide—Constipation—Temozolomide—melanoma	4e-05	0.000704	CcSEcCtD
Ifosfamide—Feeling abnormal—Carmustine—melanoma	3.98e-05	0.000702	CcSEcCtD
Ifosfamide—Asthenia—Bleomycin—melanoma	3.97e-05	0.0007	CcSEcCtD
Ifosfamide—Angiopathy—Docetaxel—melanoma	3.97e-05	0.000699	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Carmustine—melanoma	3.95e-05	0.000697	CcSEcCtD
Ifosfamide—Immune system disorder—Docetaxel—melanoma	3.95e-05	0.000696	CcSEcCtD
Ifosfamide—Mediastinal disorder—Docetaxel—melanoma	3.94e-05	0.000695	CcSEcCtD
Ifosfamide—Chills—Docetaxel—melanoma	3.92e-05	0.000691	CcSEcCtD
Ifosfamide—Pruritus—Bleomycin—melanoma	3.92e-05	0.000691	CcSEcCtD
Ifosfamide—Arrhythmia—Docetaxel—melanoma	3.91e-05	0.000688	CcSEcCtD
Ifosfamide—Alopecia—Docetaxel—melanoma	3.86e-05	0.000681	CcSEcCtD
Ifosfamide—Feeling abnormal—Temozolomide—melanoma	3.85e-05	0.000678	CcSEcCtD
Ifosfamide—Mental disorder—Docetaxel—melanoma	3.83e-05	0.000675	CcSEcCtD
Ifosfamide—Abdominal pain—Carmustine—melanoma	3.82e-05	0.000673	CcSEcCtD
Ifosfamide—Body temperature increased—Carmustine—melanoma	3.82e-05	0.000673	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Temozolomide—melanoma	3.82e-05	0.000673	CcSEcCtD
Ifosfamide—Malnutrition—Docetaxel—melanoma	3.81e-05	0.000671	CcSEcCtD
Ifosfamide—Erythema—Docetaxel—melanoma	3.81e-05	0.000671	CcSEcCtD
Ifosfamide—Hypersensitivity—Dactinomycin—melanoma	3.81e-05	0.000671	CcSEcCtD
Ifosfamide—Urticaria—Temozolomide—melanoma	3.71e-05	0.000654	CcSEcCtD
Ifosfamide—Asthenia—Dactinomycin—melanoma	3.71e-05	0.000653	CcSEcCtD
Ifosfamide—Abdominal pain—Temozolomide—melanoma	3.69e-05	0.000651	CcSEcCtD
Ifosfamide—Body temperature increased—Temozolomide—melanoma	3.69e-05	0.000651	CcSEcCtD
Ifosfamide—Hypersensitivity—Carmustine—melanoma	3.56e-05	0.000628	CcSEcCtD
Ifosfamide—Diarrhoea—Dactinomycin—melanoma	3.53e-05	0.000623	CcSEcCtD
Ifosfamide—Vomiting—Bleomycin—melanoma	3.52e-05	0.000621	CcSEcCtD
Ifosfamide—Anaemia—Docetaxel—melanoma	3.52e-05	0.00062	CcSEcCtD
Ifosfamide—Rash—Bleomycin—melanoma	3.49e-05	0.000615	CcSEcCtD
Ifosfamide—Dermatitis—Bleomycin—melanoma	3.49e-05	0.000615	CcSEcCtD
Ifosfamide—Asthenia—Carmustine—melanoma	3.47e-05	0.000611	CcSEcCtD
Ifosfamide—Hypersensitivity—Temozolomide—melanoma	3.44e-05	0.000607	CcSEcCtD
Ifosfamide—Leukopenia—Docetaxel—melanoma	3.41e-05	0.0006	CcSEcCtD
Ifosfamide—Palpitations—Docetaxel—melanoma	3.36e-05	0.000593	CcSEcCtD
Ifosfamide—Asthenia—Temozolomide—melanoma	3.35e-05	0.000591	CcSEcCtD
Ifosfamide—Cough—Docetaxel—melanoma	3.32e-05	0.000585	CcSEcCtD
Ifosfamide—Diarrhoea—Carmustine—melanoma	3.31e-05	0.000583	CcSEcCtD
Ifosfamide—Pruritus—Temozolomide—melanoma	3.31e-05	0.000582	CcSEcCtD
Ifosfamide—Convulsion—Docetaxel—melanoma	3.3e-05	0.000581	CcSEcCtD
Ifosfamide—Nausea—Bleomycin—melanoma	3.29e-05	0.00058	CcSEcCtD
Ifosfamide—Hypertension—Docetaxel—melanoma	3.29e-05	0.000579	CcSEcCtD
Ifosfamide—Vomiting—Dactinomycin—melanoma	3.28e-05	0.000579	CcSEcCtD
Ifosfamide—Rash—Dactinomycin—melanoma	3.26e-05	0.000574	CcSEcCtD
Ifosfamide—Myalgia—Docetaxel—melanoma	3.24e-05	0.000571	CcSEcCtD
Ifosfamide—Arthralgia—Docetaxel—melanoma	3.24e-05	0.000571	CcSEcCtD
Ifosfamide—Chest pain—Docetaxel—melanoma	3.24e-05	0.000571	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	3.22e-05	0.000567	CcSEcCtD
Ifosfamide—Dizziness—Carmustine—melanoma	3.2e-05	0.000563	CcSEcCtD
Ifosfamide—Diarrhoea—Temozolomide—melanoma	3.2e-05	0.000563	CcSEcCtD
Ifosfamide—Confusional state—Docetaxel—melanoma	3.13e-05	0.000552	CcSEcCtD
Ifosfamide—Oedema—Docetaxel—melanoma	3.11e-05	0.000547	CcSEcCtD
Ifosfamide—Anaphylactic shock—Docetaxel—melanoma	3.11e-05	0.000547	CcSEcCtD
Ifosfamide—Dizziness—Temozolomide—melanoma	3.09e-05	0.000544	CcSEcCtD
Ifosfamide—Infection—Docetaxel—melanoma	3.09e-05	0.000544	CcSEcCtD
Ifosfamide—Vomiting—Carmustine—melanoma	3.07e-05	0.000542	CcSEcCtD
Ifosfamide—Nausea—Dactinomycin—melanoma	3.07e-05	0.000541	CcSEcCtD
Ifosfamide—Rash—Carmustine—melanoma	3.05e-05	0.000537	CcSEcCtD
Ifosfamide—Nervous system disorder—Docetaxel—melanoma	3.05e-05	0.000537	CcSEcCtD
Ifosfamide—Dermatitis—Carmustine—melanoma	3.05e-05	0.000537	CcSEcCtD
Ifosfamide—Thrombocytopenia—Docetaxel—melanoma	3.04e-05	0.000536	CcSEcCtD
Ifosfamide—Skin disorder—Docetaxel—melanoma	3.02e-05	0.000532	CcSEcCtD
Ifosfamide—Vomiting—Temozolomide—melanoma	2.97e-05	0.000523	CcSEcCtD
Ifosfamide—Anorexia—Docetaxel—melanoma	2.96e-05	0.000522	CcSEcCtD
Ifosfamide—Rash—Temozolomide—melanoma	2.95e-05	0.000519	CcSEcCtD
Ifosfamide—Dermatitis—Temozolomide—melanoma	2.94e-05	0.000519	CcSEcCtD
Ifosfamide—Hypotension—Docetaxel—melanoma	2.9e-05	0.000512	CcSEcCtD
Ifosfamide—Nausea—Carmustine—melanoma	2.87e-05	0.000506	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Docetaxel—melanoma	2.83e-05	0.000499	CcSEcCtD
Ifosfamide—Paraesthesia—Docetaxel—melanoma	2.79e-05	0.000492	CcSEcCtD
Ifosfamide—Nausea—Temozolomide—melanoma	2.78e-05	0.000489	CcSEcCtD
Ifosfamide—Dyspnoea—Docetaxel—melanoma	2.77e-05	0.000488	CcSEcCtD
Ifosfamide—Somnolence—Docetaxel—melanoma	2.76e-05	0.000487	CcSEcCtD
Ifosfamide—Decreased appetite—Docetaxel—melanoma	2.7e-05	0.000476	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Docetaxel—melanoma	2.68e-05	0.000473	CcSEcCtD
Ifosfamide—Fatigue—Docetaxel—melanoma	2.68e-05	0.000472	CcSEcCtD
Ifosfamide—Pain—Docetaxel—melanoma	2.66e-05	0.000468	CcSEcCtD
Ifosfamide—Constipation—Docetaxel—melanoma	2.66e-05	0.000468	CcSEcCtD
Ifosfamide—Feeling abnormal—Docetaxel—melanoma	2.56e-05	0.000451	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Docetaxel—melanoma	2.54e-05	0.000448	CcSEcCtD
Ifosfamide—Body temperature increased—Docetaxel—melanoma	2.46e-05	0.000433	CcSEcCtD
Ifosfamide—Abdominal pain—Docetaxel—melanoma	2.46e-05	0.000433	CcSEcCtD
Ifosfamide—Hypersensitivity—Docetaxel—melanoma	2.29e-05	0.000403	CcSEcCtD
Ifosfamide—Asthenia—Docetaxel—melanoma	2.23e-05	0.000393	CcSEcCtD
Ifosfamide—Pruritus—Docetaxel—melanoma	2.2e-05	0.000387	CcSEcCtD
Ifosfamide—Diarrhoea—Docetaxel—melanoma	2.13e-05	0.000375	CcSEcCtD
Ifosfamide—Dizziness—Docetaxel—melanoma	2.05e-05	0.000362	CcSEcCtD
Ifosfamide—Vomiting—Docetaxel—melanoma	1.98e-05	0.000348	CcSEcCtD
Ifosfamide—Rash—Docetaxel—melanoma	1.96e-05	0.000345	CcSEcCtD
Ifosfamide—Dermatitis—Docetaxel—melanoma	1.96e-05	0.000345	CcSEcCtD
Ifosfamide—Nausea—Docetaxel—melanoma	1.85e-05	0.000325	CcSEcCtD
Ifosfamide—CYP2C19—Metabolism—PHGDH—melanoma	1.97e-06	0.000392	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.97e-06	0.000392	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PRKCA—melanoma	1.96e-06	0.00039	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.95e-06	0.000389	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PLA2G6—melanoma	1.95e-06	0.000388	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—ERCC2—melanoma	1.94e-06	0.000387	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—HPSE—melanoma	1.93e-06	0.000384	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GNA11—melanoma	1.93e-06	0.000384	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.93e-06	0.000384	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HS3ST5—melanoma	1.92e-06	0.000381	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CUBN—melanoma	1.89e-06	0.000377	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—FASN—melanoma	1.89e-06	0.000376	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP17A1—melanoma	1.87e-06	0.000373	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GNA11—melanoma	1.87e-06	0.000372	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—SLC5A5—melanoma	1.86e-06	0.00037	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—FASN—melanoma	1.83e-06	0.000364	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—BSG—melanoma	1.83e-06	0.000364	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SDHD—melanoma	1.83e-06	0.000364	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CSPG4—melanoma	1.83e-06	0.000364	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—SLC5A5—melanoma	1.8e-06	0.000358	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PHGDH—melanoma	1.79e-06	0.000357	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—LUM—melanoma	1.79e-06	0.000357	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GNAQ—melanoma	1.79e-06	0.000357	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CD44—melanoma	1.79e-06	0.000357	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—VCAN—melanoma	1.79e-06	0.000356	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GPAM—melanoma	1.77e-06	0.000353	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GNA11—melanoma	1.77e-06	0.000352	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—HPSE—melanoma	1.76e-06	0.00035	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—VCAN—melanoma	1.75e-06	0.000348	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CD44—melanoma	1.74e-06	0.000346	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GNAQ—melanoma	1.74e-06	0.000346	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—FASN—melanoma	1.73e-06	0.000344	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CUBN—melanoma	1.73e-06	0.000344	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP1B1—melanoma	1.72e-06	0.000342	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.7e-06	0.000339	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—SLC5A5—melanoma	1.7e-06	0.000339	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PLA2G6—melanoma	1.69e-06	0.000336	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.69e-06	0.000336	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SDHD—melanoma	1.67e-06	0.000332	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CSPG4—melanoma	1.67e-06	0.000332	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—BSG—melanoma	1.67e-06	0.000332	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP1B1—melanoma	1.67e-06	0.000332	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GNAQ—melanoma	1.64e-06	0.000327	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CD44—melanoma	1.64e-06	0.000327	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GPAM—melanoma	1.62e-06	0.000321	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP1B1—melanoma	1.58e-06	0.000314	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CG—melanoma	1.54e-06	0.000306	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—VCAN—melanoma	1.52e-06	0.000302	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP17A1—melanoma	1.51e-06	0.000301	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PLA2G6—melanoma	1.51e-06	0.0003	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PPARG—melanoma	1.48e-06	0.000295	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP17A1—melanoma	1.48e-06	0.000294	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.47e-06	0.000293	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PLCB4—melanoma	1.45e-06	0.000289	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.44e-06	0.000286	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GNA11—melanoma	1.43e-06	0.000284	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ABCB1—melanoma	1.42e-06	0.000282	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—FASN—melanoma	1.4e-06	0.000278	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GNA11—melanoma	1.4e-06	0.000278	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.39e-06	0.000276	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PLA2G6—melanoma	1.37e-06	0.000273	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—SLC5A5—melanoma	1.37e-06	0.000273	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ABCB1—melanoma	1.37e-06	0.000273	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC6A11—melanoma	1.37e-06	0.000272	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIP4K2A—melanoma	1.37e-06	0.000272	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—FASN—melanoma	1.37e-06	0.000272	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—VCAN—melanoma	1.35e-06	0.000269	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CD—melanoma	1.35e-06	0.000269	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—SLC5A5—melanoma	1.34e-06	0.000267	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—ALB—melanoma	1.33e-06	0.000265	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—MTAP—melanoma	1.33e-06	0.000264	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CD44—melanoma	1.33e-06	0.000264	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GNAQ—melanoma	1.33e-06	0.000264	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PRKCA—melanoma	1.3e-06	0.000259	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ABCB1—melanoma	1.3e-06	0.000258	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CD44—melanoma	1.3e-06	0.000258	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GNAQ—melanoma	1.3e-06	0.000258	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ERCC2—melanoma	1.29e-06	0.000257	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.28e-06	0.000255	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP17A1—melanoma	1.28e-06	0.000255	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP1B1—melanoma	1.27e-06	0.000253	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PRKCA—melanoma	1.26e-06	0.000251	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.26e-06	0.000251	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ERCC2—melanoma	1.25e-06	0.000249	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.25e-06	0.000248	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP1B1—melanoma	1.24e-06	0.000247	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.24e-06	0.000246	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—VCAN—melanoma	1.23e-06	0.000246	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GNA11—melanoma	1.21e-06	0.00024	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PRKCA—melanoma	1.19e-06	0.000238	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ERCC2—melanoma	1.19e-06	0.000236	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PHGDH—melanoma	1.18e-06	0.000235	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—LUM—melanoma	1.18e-06	0.000235	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—FASN—melanoma	1.18e-06	0.000235	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CB—melanoma	1.18e-06	0.000234	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.17e-06	0.000232	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTGS2—melanoma	1.17e-06	0.000232	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—SLC5A5—melanoma	1.16e-06	0.000231	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HPSE—melanoma	1.16e-06	0.000231	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP17A1—melanoma	1.14e-06	0.000227	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CUBN—melanoma	1.14e-06	0.000227	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.13e-06	0.000224	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.13e-06	0.000224	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CD44—melanoma	1.12e-06	0.000223	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GNAQ—melanoma	1.12e-06	0.000223	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.11e-06	0.000221	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SDHD—melanoma	1.1e-06	0.000219	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—BSG—melanoma	1.1e-06	0.000219	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CSPG4—melanoma	1.1e-06	0.000219	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.1e-06	0.000219	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.09e-06	0.000217	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GNA11—melanoma	1.08e-06	0.000215	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP1B1—melanoma	1.08e-06	0.000214	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GPAM—melanoma	1.07e-06	0.000212	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—FASN—melanoma	1.06e-06	0.00021	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ABCB1—melanoma	1.05e-06	0.000208	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP17A1—melanoma	1.04e-06	0.000207	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SLC5A5—melanoma	1.04e-06	0.000207	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.04e-06	0.000207	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.03e-06	0.000204	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ABCB1—melanoma	1.02e-06	0.000204	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CG—melanoma	1.02e-06	0.000203	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTEN—melanoma	1.02e-06	0.000202	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.01e-06	0.000202	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GNAQ—melanoma	1e-06	0.000199	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CD44—melanoma	1e-06	0.000199	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CG—melanoma	9.9e-07	0.000197	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PPARG—melanoma	9.85e-07	0.000196	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GNA11—melanoma	9.83e-07	0.000196	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.82e-07	0.000195	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.73e-07	0.000194	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PRKCA—melanoma	9.64e-07	0.000192	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—FASN—melanoma	9.62e-07	0.000191	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP1B1—melanoma	9.61e-07	0.000191	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ERCC2—melanoma	9.56e-07	0.00019	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PPARG—melanoma	9.55e-07	0.00019	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.5e-07	0.000189	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SLC5A5—melanoma	9.47e-07	0.000188	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PRKCA—melanoma	9.42e-07	0.000187	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CG—melanoma	9.36e-07	0.000186	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ERCC2—melanoma	9.35e-07	0.000186	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GNAQ—melanoma	9.14e-07	0.000182	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CD44—melanoma	9.14e-07	0.000182	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PLA2G6—melanoma	9.06e-07	0.00018	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PPARG—melanoma	9.03e-07	0.00018	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CD—melanoma	8.98e-07	0.000179	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.95e-07	0.000178	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.87e-07	0.000176	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ABCB1—melanoma	8.87e-07	0.000176	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ALB—melanoma	8.86e-07	0.000176	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP1B1—melanoma	8.77e-07	0.000174	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CD—melanoma	8.7e-07	0.000173	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ALB—melanoma	8.59e-07	0.000171	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.48e-07	0.000169	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CD—melanoma	8.23e-07	0.000164	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PRKCA—melanoma	8.16e-07	0.000162	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—VCAN—melanoma	8.14e-07	0.000162	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ALB—melanoma	8.12e-07	0.000162	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ERCC2—melanoma	8.09e-07	0.000161	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ABCB1—melanoma	7.92e-07	0.000157	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CB—melanoma	7.82e-07	0.000156	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTGS2—melanoma	7.75e-07	0.000154	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.74e-07	0.000154	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CB—melanoma	7.58e-07	0.000151	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CG—melanoma	7.55e-07	0.00015	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTGS2—melanoma	7.51e-07	0.000149	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CG—melanoma	7.38e-07	0.000147	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PPARG—melanoma	7.29e-07	0.000145	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PRKCA—melanoma	7.29e-07	0.000145	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ERCC2—melanoma	7.23e-07	0.000144	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ABCB1—melanoma	7.22e-07	0.000144	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CA—melanoma	7.17e-07	0.000143	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CB—melanoma	7.17e-07	0.000143	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PPARG—melanoma	7.12e-07	0.000142	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTGS2—melanoma	7.11e-07	0.000141	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP17A1—melanoma	6.87e-07	0.000137	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTEN—melanoma	6.76e-07	0.000134	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.71e-07	0.000133	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PRKCA—melanoma	6.64e-07	0.000132	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CD—melanoma	6.64e-07	0.000132	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ERCC2—melanoma	6.59e-07	0.000131	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ALB—melanoma	6.55e-07	0.00013	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTEN—melanoma	6.55e-07	0.00013	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CD—melanoma	6.49e-07	0.000129	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GNA11—melanoma	6.49e-07	0.000129	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ALB—melanoma	6.41e-07	0.000127	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CG—melanoma	6.39e-07	0.000127	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—FASN—melanoma	6.35e-07	0.000126	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC5A5—melanoma	6.24e-07	0.000124	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTEN—melanoma	6.2e-07	0.000123	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PPARG—melanoma	6.17e-07	0.000123	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CD44—melanoma	6.03e-07	0.00012	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GNAQ—melanoma	6.03e-07	0.00012	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.99e-07	0.000119	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKT1—melanoma	5.86e-07	0.000117	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CB—melanoma	5.79e-07	0.000115	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP1B1—melanoma	5.78e-07	0.000115	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTGS2—melanoma	5.73e-07	0.000114	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CG—melanoma	5.71e-07	0.000114	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CB—melanoma	5.66e-07	0.000113	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CD—melanoma	5.62e-07	0.000112	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTGS2—melanoma	5.6e-07	0.000111	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALB—melanoma	5.55e-07	0.00011	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPARG—melanoma	5.51e-07	0.00011	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.46e-07	0.000109	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CG—melanoma	5.2e-07	0.000104	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPARG—melanoma	5.02e-07	9.99e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CD—melanoma	5.02e-07	9.98e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTEN—melanoma	5e-07	9.95e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALB—melanoma	4.95e-07	9.85e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CB—melanoma	4.9e-07	9.74e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTEN—melanoma	4.89e-07	9.72e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTGS2—melanoma	4.85e-07	9.66e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CA—melanoma	4.77e-07	9.49e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ABCB1—melanoma	4.76e-07	9.47e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CA—melanoma	4.62e-07	9.2e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CD—melanoma	4.57e-07	9.1e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALB—melanoma	4.52e-07	8.98e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PRKCA—melanoma	4.38e-07	8.71e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CB—melanoma	4.37e-07	8.7e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CA—melanoma	4.37e-07	8.7e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ERCC2—melanoma	4.34e-07	8.64e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTGS2—melanoma	4.33e-07	8.62e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTEN—melanoma	4.23e-07	8.42e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CB—melanoma	3.99e-07	7.93e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTGS2—melanoma	3.95e-07	7.86e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKT1—melanoma	3.9e-07	7.75e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTEN—melanoma	3.78e-07	7.52e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKT1—melanoma	3.78e-07	7.51e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKT1—melanoma	3.57e-07	7.1e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CA—melanoma	3.53e-07	7.02e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CA—melanoma	3.45e-07	6.86e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTEN—melanoma	3.45e-07	6.85e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CG—melanoma	3.43e-07	6.83e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPARG—melanoma	3.31e-07	6.59e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CD—melanoma	3.02e-07	6e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CA—melanoma	2.99e-07	5.94e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALB—melanoma	2.98e-07	5.92e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKT1—melanoma	2.88e-07	5.73e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKT1—melanoma	2.82e-07	5.6e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CA—melanoma	2.67e-07	5.3e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CB—melanoma	2.63e-07	5.23e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTGS2—melanoma	2.61e-07	5.18e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKT1—melanoma	2.44e-07	4.85e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CA—melanoma	2.43e-07	4.83e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTEN—melanoma	2.27e-07	4.52e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKT1—melanoma	2.18e-07	4.33e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKT1—melanoma	1.99e-07	3.95e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CA—melanoma	1.6e-07	3.19e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKT1—melanoma	1.31e-07	2.6e-05	CbGpPWpGaD
